Log In
Print
BCIQ
Print
Print this Print this
 

Cerezyme, imiglucerase

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionRecombinant glucocerebrosidase
Molecular Target Not available
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentMarketed
Standard IndicationGaucher's disease
Indication DetailsImprove bone mineral density (BMD) in Type I Gaucher's disease patients; Treat Type I Gaucher's disease
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today